Marija Vavlukis
Overview
Explore the profile of Marija Vavlukis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
587
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fabin N, Cenko E, Bergami M, Yoon J, Vadala G, Mendieta G, et al.
Cardiovasc Res
. 2024 Aug;
120(16):2064-2077.
PMID: 39196713
Aims: To investigate the impact of an early coronary revascularization (<24 h) compared with initial conservative strategy on clinical outcomes in diabetic patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS)...
2.
Guarracino F, Vavlukis M
Front Cardiovasc Med
. 2024 Aug;
11:1446904.
PMID: 39165258
No abstract available.
3.
Cenko E, Manfrini O, Yoon J, van der Schaar M, Bergami M, Vasiljevic Z, et al.
JACC Adv
. 2024 Jun;
2(3):100294.
PMID: 38939586
Background: There have been conflicting reports regarding outcomes in women presenting with an acute coronary syndrome (ACS). Objectives: The objective of the study was to examine sex-specific differences in 30-day...
4.
Cenko E, Yoon J, Bergami M, Gale C, Vasiljevic Z, Vavlukis M, et al.
Eur Heart J Qual Care Clin Outcomes
. 2024 May;
PMID: 38714331
Background: Existing data on female sex and excess cardiovascular mortality after myocardial infarction (MI) mostly come from high-income countries (HICs). This study aimed to investigate how sex disparities in treatments...
5.
Bugiardini R, Cenko E, Yoon J, Bergami M, Vasiljevic Z, Mendieta G, et al.
Lancet Reg Health Eur
. 2024 Mar;
38:100824.
PMID: 38476741
Background: The age-standardized death rates under 65 years from ischemic heart disease in South Eastern Europe are approximately twice as high than the Western Europe average, but the reasons are...
6.
Stojmenski A, Gusev M, Chorbev I, Tudjarski S, Poposka L, Vavlukis M
Sensors (Basel)
. 2023 Nov;
23(21).
PMID: 37960397
Heart rate variability (HRV) parameters can reveal the performance of the autonomic nervous system and possibly estimate the type of its malfunction, such as that of detecting the blood glucose...
7.
Vavlukis A, Mladenovska K, Davalieva K, Vavlukis M, Dimovski A
Acta Pharm
. 2023 Sep;
73(3):363-384.
PMID: 37708957
The advancements in proteomics have provided a better understanding of the functionality of apolipoproteins and lipoprotein-associated proteins, with the HDL lipoprotein fraction being the most studied. The focus of this...
8.
Antoniades C, Tousoulis D, Vavlukis M, Fleming I, Duncker D, Eringa E, et al.
Eur Heart J
. 2023 Aug;
44(38):3827-3844.
PMID: 37599464
Obesity is a modifiable cardiovascular risk factor, but adipose tissue (AT) depots in humans are anatomically, histologically, and functionally heterogeneous. For example, visceral AT is a pro-atherogenic secretory AT depot,...
9.
Bergami M, Manfrini O, Nava S, Caramori G, Yoon J, Badimon L, et al.
J Am Heart Assoc
. 2023 Jul;
12(14):e028939.
PMID: 37449568
Background Empiric antimicrobial therapy with azithromycin is highly used in patients admitted to the hospital with COVID-19, despite prior research suggesting that azithromycin may be associated with increased risk of...
10.
Bugiardini R, Nava S, Caramori G, Yoon J, Badimon L, Bergami M, et al.
Cardiovasc Res
. 2023 Jan;
119(5):1190-1201.
PMID: 36651866
Aims: Previous analyses on sex differences in case fatality rates at population-level data had limited adjustment for key patient clinical characteristics thought to be associated with coronavirus disease 2019 (COVID-19)...